[ad_1] The number of clinical trials using cannabis-based medicines to treat patients with symptoms from a variety of conditions, including cancer, epilepsy, and autism spectrum disorder, has increased dramatically since 2010, a new report found. Analysis and findings have been published this week by Prohibition Partners in The Pharmaceutical Cannabis Report: 3rd Edition, in collaboration with Cannabiscientia, just hours before the US Department of Health and Human Services (HHS) sent a recommendation to the Drug Enforcement…
"More than 600% Increase in Cannabis Clinical Trials Since 2010"